These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 2780659

  • 1. When is a cystectomy necessary in carcinoma in situ?
    Herr HW.
    Prog Clin Biol Res; 1989; 303():511-5. PubMed ID: 2780659
    [No Abstract] [Full Text] [Related]

  • 2. Intravesical Bacillus Calmette Guerin therapy in patients with superficial bladder tumor.
    Steg A, Belas M, Leleu C, Boccon-Gibod L.
    Prog Clin Biol Res; 1989; 303():375-81. PubMed ID: 2780654
    [No Abstract] [Full Text] [Related]

  • 3. BCG in the management of superficial bladder cancer.
    Guinan P, Richardson C, Hanna M, Rubenstein M.
    Prog Clin Biol Res; 1989; 303():447-53. PubMed ID: 2675002
    [Abstract] [Full Text] [Related]

  • 4. [The influence over the long-term prognosis of BCG therapy and the surgical treatment in superficial bladder cancer treatment].
    Higashi S, Matsui Y, Takahashi T, Nishiyama H, Ito N, Yamamoto S, Kamoto T, Ogawa O.
    Hinyokika Kiyo; 2005 Aug; 51(8):529-31. PubMed ID: 16164268
    [Abstract] [Full Text] [Related]

  • 5. Pathologic and structural changes in the bladder after BCG intravesical therapy in men.
    Pagano F, Bassi P, Milani C, Dalla Palma P, Rebuffi AG, Poletti A, Parenti A.
    Prog Clin Biol Res; 1989 Aug; 310():81-91. PubMed ID: 2771996
    [No Abstract] [Full Text] [Related]

  • 6. BCG therapy of superficial bladder tumors.
    Herr HW.
    Prog Clin Biol Res; 1989 Aug; 303():369-74. PubMed ID: 2674999
    [No Abstract] [Full Text] [Related]

  • 7. [Intravesical immunotherapy of in situ carcinoma of the urinary bladder using Bacillus Calmette-Guerin (BCG)].
    Jakse G.
    Wien Klin Wochenschr; 1987 Feb 20; 99(4):114-8. PubMed ID: 3577186
    [Abstract] [Full Text] [Related]

  • 8. Management of flat carcinoma in situ of the bladder.
    Whitmore WF.
    Prog Clin Biol Res; 1984 Feb 20; 162B():219-24. PubMed ID: 6504897
    [No Abstract] [Full Text] [Related]

  • 9. [Clinical observation of 8 cases of carcinoma in situ of the urinary bladder].
    Murase T, Ito H, Ohishi M, Takashi M.
    Hinyokika Kiyo; 1989 Apr 20; 35(4):583-5. PubMed ID: 2735263
    [Abstract] [Full Text] [Related]

  • 10. Superficial bladder disease: case studies and therapeutic advances.
    Soloway MS, Droller MJ, Flanigan RC, Nseyo UO.
    Urology; 1992 Dec 20; 40(6 Suppl):11-22. PubMed ID: 1466118
    [No Abstract] [Full Text] [Related]

  • 11. [Clinical study of primary carcinoma in situ of the bladder].
    Mori Y, Shima H, Ihara H, Yabumoto H, Taguchi K, Koike H, Nojima M, Yamamoto H, Ikoma F.
    Hinyokika Kiyo; 1996 Jan 20; 42(1):17-21. PubMed ID: 8686577
    [Abstract] [Full Text] [Related]

  • 12. Intravesical BCG therapy in patients with superficial bladder tumors.
    Steg A, Belas M, Leleu C, Boccon-Gibod L.
    Prog Clin Biol Res; 1989 Jan 20; 310():153-60. PubMed ID: 2771990
    [No Abstract] [Full Text] [Related]

  • 13. Percutaneous BCG perfusion of the upper urinary tract for carcinoma in situ.
    Studer UE, Casanova G, Kraft R, Zingg EJ.
    Prog Clin Biol Res; 1990 Jan 20; 350():81-6. PubMed ID: 2385611
    [No Abstract] [Full Text] [Related]

  • 14. [Intravesical bacillus Calmette-Guerin therapy for superficial bladder tumor: experience of 13 cases].
    Okuno H, Shirahase T, Kihara Y, Arai Y.
    Hinyokika Kiyo; 1989 Sep 20; 35(9):1503-7. PubMed ID: 2816616
    [Abstract] [Full Text] [Related]

  • 15. Intravesical adjuvant treatment in superficial bladder cancer. A review of the question after 15 years of experience with the EORTC GU group.
    Bouffioux C.
    Scand J Urol Nephrol Suppl; 1991 Sep 20; 138():167-77. PubMed ID: 1838428
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of superficial bladder cancer.
    Grossman HB.
    Compr Ther; 1995 May 20; 21(5):245-8. PubMed ID: 7621655
    [No Abstract] [Full Text] [Related]

  • 17. Carcinoma in situ of the bladder.
    Herr HW.
    Semin Urol; 1983 Feb 20; 1(1):15-22. PubMed ID: 6679095
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Results of adjuvant intravesical Bacillus Calmette-Guérin therapy for grade 3 superficial bladder cancer].
    Yumura Y, Oogo Y, Takase K, Hamano A, Yamashita Y, Noguchi S, Satomi Y.
    Hinyokika Kiyo; 2004 Nov 20; 50(11):767-71. PubMed ID: 15628536
    [Abstract] [Full Text] [Related]

  • 20. BCG-RIVM intravesical immunoprophylaxis for superficial bladder cancer.
    Debruyne FM, van der Meijden AP, Schreinemachers LM, Geboers AD, Franssen MP, van Leeuwen MJ, Steerenberg PA, de Jong WH, Ruitenberg EJ.
    Prog Clin Biol Res; 1988 Nov 20; 269():511-24. PubMed ID: 3134662
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.